EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable for Genomic Surveillance Within Clinical Diagnostic Settings

Derek Tshiabuila, Wonderful Choga, James E San iD, Tongai Maponga, Gert Van Zyl iD, Jennifer Giandhari iD, Sureshnee Pillay, Wolfgang Preiser iD, Yeshnee Naidoo, Cheryl Baxter iD, Darren P Martin, Tulio de Oliveira

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111702 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Derek Tshiabuila und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Epidemic Response and Innovation (CERI), Stellenbosch University, Stellenbosch 7600, South Africa. Hauptthemen laut MEDLINE: Hepatitis B virus, Genome, Viral, Genotype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Rockefeller Foundation, Abbott Pandemic Defence Coalition (APDC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic Hepatitis B Virus (HBV) infection remains a significant public health concern, particularly in Africa, where the burden is substantial. HBV is an enveloped virus, classified into ten phylogenetically distinct genotypes (A–J). Tests to determine HBV genotypes are based on full-genome sequencing or reverse hybridization. In practice, both approaches have limitations. Whereas diagnostic sequencing, generally using the Sanger approach, tends to focus only on the S-gene and yields little or no information on intra-patient HBV genetic diversity, reverse hybridization detects only known genotype-specific mutations. To resolve these limitations, we developed an Oxford Nanopore Technology (ONT)-based HBV diagnostic sequencing protocol suitable for clinical virology that yields both complete genome sequences and extensive intra-patient HBV diversity data. Specifically, the protocol involves tiling-based PCR amplification of HBV sequences, library preparation using the ONT Rapid Barcoding Kit (Oxford nanopore Technologies, Oxford, OX4 4DQ, UK), ONT GridION sequencing, genotyping using genome detective software v1.132/1.133, a recombination analysis using jpHMM (26 October 2011 version) and RDP5.61 software, and drug resistance profiling using Geno2pheno v2.0 software. We prove the utility of our protocol by efficiently generating and characterizing high-quality near full-length HBV genomes from 148 residual diagnostic samples from HBV-infected patients in the Western Cape province of South Africa, providing valuable insights into the genetic diversity and epidemiology of HBV in this region of the world.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusGenome, ViralGenotypeHumansNanopore SequencingHepatitis B, ChronicPhylogenyHigh-Throughput Nucleotide SequencingDNA, ViralSequence Analysis, DNAGenomicsNanoporesDrug Resistance, ViralHepatitis BGenetic Variation

Stichwörter der Autor:innen

HBVNGSONTrecombinationwhole-genome sequencing

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Centre for Epidemic Response and Innovation (CERI), Stellenbosch University, Stellenbosch 7600, South Africa.
  • Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Division of Medical Virology, National Health Laboratory Service Tygerberg, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 8000, South Africa.
  • KwaZulu Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu Natal, Durban 4001, South Africa.
  • Computational Biology Division, Department of Integrative Biomedical Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town 8000, South Africa.

ORCID-Profile: James E San, Gert Van Zyl, Jennifer Giandhari, Wolfgang Preiser, Cheryl Baxter

Förderung

  • NIAID NIH HHS
  • Rockefeller Foundation
  • Abbott Pandemic Defence Coalition (APDC)
  • National Institute of Health USA
  • Global Health EDCTP3 Joint Undertaking
  • Bill and Melinda Gates Foundation
  • European Union’s Horizon Europe Research and Innovation Programme
  • Health Emergency Preparedness and Response Umbrella Program

Zitieren

APA

Tshiabuila, D., Choga, W., San, J. E., Maponga, T., Van Zyl, G., Giandhari, J., Pillay, S., Preiser, W., Naidoo, Y., Baxter, C., Martin, D. P., & de Oliveira, T. (2024). An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable for Genomic Surveillance Within Clinical Diagnostic Settings. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111702

Vancouver

Tshiabuila D, Choga W, San JE, Maponga T, Van Zyl G, Giandhari J, et al. An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable for Genomic Surveillance Within Clinical Diagnostic Settings. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111702

BibTeX
@article{Tshiabuila2024,
  author = {Tshiabuila, Derek and Choga, Wonderful and San, James E and Maponga, Tongai and Van Zyl, Gert and Giandhari, Jennifer and Pillay, Sureshnee and Preiser, Wolfgang and Naidoo, Yeshnee and Baxter, Cheryl and Martin, Darren P and de Oliveira, Tulio},
  title = {An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable for Genomic Surveillance Within Clinical Diagnostic Settings},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111702}
}
Kostenlos starten →